YOKNEAM, Israel, Sept. 5, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in September:
Baird Healthcare Conference
Presenters: Yair Malca, Chief Financial Officer and Dr. Spero Theodorou, Chief Medical Officer
Format: In-person fireside chat moderated by Jeff Johnson, Senior Equity Analyst, and one-on-one meetings
Location: New York, NY
When: Tuesday, Sept. 12 at 11:25 am ET
A live webcast of the presentation can be accessed here.
Piper Sandler Aesthetics Day
Presenters: Yair Malca, Chief Financial Officer, Wanda Cummings, RN and Vice President of Clinical Operations, North America and Dr. Christopher Chia, double board-certified Plastic Surgeon and Surgical Director of bodySCULPT
Format: In-person investor bus tour and demo at bodySCULPT, an InMode certified plastic and cosmetic surgery center in NYC
Location: New York, NY
When: Wednesday, Sept. 27 at 1:00 pm ET
Cantor Global Healthcare Conference
Presenters: Yair Malca, Chief Financial Officer
Format: In-person fireside chat moderated by Ross Osborn, Senior Equity Analyst, and one-on-one meetings
Location: New York, NY
When: Thursday, Sept. 28 at 10:55 am ET
A live webcast of the presentation can be accessed here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
This email address is being protected from spambots. You need JavaScript enabled to view it.
917-607-8654
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
Last Trade: | US$17.08 |
Daily Change: | -0.11 -0.64 |
Daily Volume: | 1,912,263 |
Market Cap: | US$1.300B |
September 04, 2024 August 06, 2024 July 31, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB